Roundup of news, deals, and data from OUI for Q1 2017.
We publish news of technology innovations, investment opportunities, together with updates from spinout & startup companies and licensees
The Oxford University spinout leads newly formed DRIVEN consortium in most ambitious autonomous vehicle trials worldwide to date.
SpyBiotech, an Oxford University spinout developing a molecular superglue for rapid development of vaccines targeting a range of diseases, secures £4m seed funding at launch, led by Oxford Sciences Innovation with participation from GV.
The Germany-based diagnostics firm is licencing out Oxford technologies to support the development of its in-vitro diagnostics for MS.
Dr Stoten will be taking over from retiring Managing Director Linda Naylor from April.
Oxford Cancer Biomarker’s ColoTox test will now be available to UK patients considering chemotherapy.
Oxford University and Evotec’s drug discovery partnership launched last year to quickly accelerate drugs to market begins making awards.